Epidemiology and clinical aspects of Novel Psychoactive Substances (NPS)
This presentation will give an overview of the emergence of novel psychoactive substances (NPS) in time. Their origin, general pharmacology and ways of marketing them to user groups are discussed.
Then, epidemiology is discussed on the basis of available data about prevalence of use. Health consequences are discussed on the basis of available clinical and toxicological literature, mainly case reports and case series.